CTRI/2014/05/004635已完成未知
A PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GREEN SLIM IN PATIENTS WITH OBESITY, DIABETES AND HIGH CHOLESTERO
Green Chem0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male and female subjects aged 18 to 60 years
- •Obese subjects with Body mass index 25 to 35 kg/m2
- •Diabetic subjects with HbA1C >= 7%
- •Moderately elevated Total serum cholesterol level
- •Subjects must understand risks and benefits of the protocol and be able to give informed consent along with audio video visual
- •Females of child-bearing potential must agree to use an approved form of birth control and to have a negative pregnancy test result
排除标准
- •Any other clinically significant disorder
- •Have a history of hypertension, Angina, stroke, thyroid diseases
- •Presently using other weight loss medications, as well as stimulants, laxatives or diuretics taken solely for the purpose of weight loss
- •Recent, unexplained weight loss or gain
- •History of HIV positive patients
- •History of hepatitis, pancreatitis, lactic acidosis or hepatomegaly with steatosis.
- •History of motor weakness or peripheral sensory neuropathy
- •Are currently participating in any clinical trial.
研究者
相似试验
已完成
不适用
A CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DIABOHERB IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.CTRI/2014/12/005286SBL PVT LTD150
进行中（未招募）
1 期
A vaccine and a device used together to treat women with precancerous cells on the cervix caused by human papillomavirus (HPV).EUCTR2016-002761-63-PLInovio Pharmaceuticals, Inc.198
进行中（未招募）
1 期
A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF 6-MONTH ACETYLCARNITINE THERAPY ON ARTERIAL BLOOD PRESSURE, LIPID AND METABOLIC PROFILE, AND KIDNEY FUNCTION IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES ON BACKGROUND SIMVASTATIN THERAPY (DIABASI STUDY) - Acetylcarnitine in type 2 diabetesDiabetesEUCTR2007-005925-31-ITIST. DI RICERCHE FARMACOLOG. M. NEGRI228
进行中（未招募）
1 期
A vaccine and a device used together to treat women with precancerous cells on the cervix caused by human papillomavirus (HPV).HPV-16 AND/OR HPV-18 RELATED HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) OF THE CERVIXMedDRA version: 20.0Level: PTClassification code 10064328Term: Human papilloma virus test positiveSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: LLTClassification code 10066237Term: Cervical high grade squamous intraepithelial lesionSystem Organ Class: 100000024086EUCTR2016-002761-63-EEInovio Pharmaceuticals, Inc.198
进行中（未招募）
1 期
A vaccine and a device used together to treat women with precancerous cells on the cervix caused by human papillomavirus (HPV).HPV-16 AND/OR HPV-18 RELATED HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) OF THE CERVIXMedDRA version: 20.1Level: PTClassification code 10064328Term: Human papilloma virus test positiveSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: LLTClassification code 10066237Term: Cervical high grade squamous intraepithelial lesionSystem Organ Class: 100000004872EUCTR2016-002761-63-CZInovio Pharmaceuticals, Inc.198